Skip to main content

Table 3 Changes in headache disability (HIT-6) and quality of life (SF-36v2 physical component score (PCS) and mental component score (MCS)) from baseline to 12 months post-microstimulator insertion are provided (mean ± SD (range))

From: Sphenopalatine ganglion stimulation for cluster headache, results from a large, open-label European registry

Analysis

HIT-6 headache disability

SF-36v2 quality of life – PCS

SF-36v2 quality of life – MCS

Baseline

12 months

Baseline

12 months

Baseline

12 months

All patients

64.3 ± 6.6 (41–78)

56.0 ± 11.1 (36–76)

40.4 ± 7.4 (23.9–57.6)

43.5 ± 10.1 (21.7–63.3)

32.2 ± 13.7 (6.0–59.7)

39.2 ± 15.0 (6.1–65.1)

p < 0.0001, n = 80

p = 0.0062, n = 79

p = 0.0003, n = 79

Therapeutic responders only

64.7 ± 6.9 (41–78)

53.2 ± 11.1 (36–74)

39.9 ± 7.7 (23.9–57.6)

45.2 ± 10.4 (22.3–63.3)

32.2 ± 12.6 (14.4–57.7)

40.8 ± 14.8 (6.1–65.1)

p < 0.0001, n = 53

p = 0.0001, n = 52

p = 0.0005, n = 52

  1. Differences were statistically significant for all patients, as well as for therapeutic responders